For over a decade, countless patients with extensive, chronic gastrointestinal complaints have found their way to my clinical nutrition practice believing that “systemic candida” — or, a pervasive ...

Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections The Medicines and Healthcare Products Regulatory Agency (MHRA) filing ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Rezafungin is a next-generation, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis and candidemia The European ...

SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing therapies designed to save lives and improve the standard of care for patients ...

Antibiotics are a well-known risk factor for invasive candidiasis, particularly among hospitalised patients given antibiotics to prevent sepsis and other nosocomial bacterial infections. However the ...

Oral candidiasis is most commonly treated with antifungal medications to control the growth of Candida in the mouth. Topical treatment with a liquid or gel that can be applied directly to the affected ...

New research shows that eosinophils, immune cells usually linked to allergies, also play a protective role against Candida infections by using the CD48 receptor to recognize the fungus and release ...

Candida die-off occurs when someone experiences new or worsening symptoms after receiving treatment for candidemia, which refers to a Candida infection in the bloodstream. Symptoms may include fever, ...